Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-21-007688
Filing Date
2021-01-26
Accepted
2021-01-26 16:49:34
Documents
7
Period of Report
2021-02-25

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm213282-2_def14a.htm DEF 14A 1407642
2 GRAPHIC lg_essa-4c.jpg GRAPHIC 21245
3 GRAPHIC lg_laurelhilladvgrp-4c.jpg GRAPHIC 42515
4 GRAPHIC tm213282d1-guide1_essa4clr.jpg GRAPHIC 772977
5 GRAPHIC tm213282d1-guide2_essa4clr.jpg GRAPHIC 576098
6 GRAPHIC tm213282d1-proxy1_essa4c.jpg GRAPHIC 755514
7 GRAPHIC tm213282d1-proxy2_essabw.jpg GRAPHIC 780335
  Complete submission text file 0001104659-21-007688.txt   5469759
Mailing Address SUITE 720 999 WEST BROADWAY VANCOUVER A1 V5Z 1K5
Business Address SUITE 720 999 WEST BROADWAY VANCOUVER A1 V5Z 1K5 (778) 331-0962
ESSA Pharma Inc. (Filer) CIK: 0001633932 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0930
Type: DEF 14A | Act: 34 | File No.: 001-37410 | Film No.: 21554740
SIC: 2834 Pharmaceutical Preparations